Hyperliquid’s HIP-4 outcome volume tripled after outside deployment opened, but incentives and U.S. regulatory barriers complicate the growth.
Hyperliquid’s HIP-4 outcome volume tripled after outside deployment opened, but incentives and U.S. regulatory barriers complicate the growth.